Program Planners – Editor, Associate Editors, and Guest Editor
Mark H. Rapaport, M.D., Editor of FOCUS, and Chairman and Chief of Psychiatric Services, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Ga. No financial relationships with commercial interests.
Dorothy Stubbe, M.D., Editor and Author, Communications Commentary, Associate Professor and Program Director, Yale University School of Medicine Child Study Center, New Haven, CT.- No financial relationships with commercial interests.
Laura Dunn, M.D., Co-Editor Ethics Column; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA; Dr. Dunn reports: Consultant: Otsuka America Pharmaceutical Inc.
Ian A. Cook, M.D., D.F.A.P.A., Section Editor and Author Patient Management: Dr. Cook is with the Semel Institute for Neuroscience and Human Behavior at the University of California, Los Angeles, and is in practice at the Los Angeles TMS Institute. Dr. Cook reports that his active biomedical device patents are assigned to the University of California. In the last year, he has advised HeartCloud, Inc., and the BrainCloud Corporation, and the University of California, Los Angeles, has received research grant funding from NeoSync, Inc., for his work. He has been granted stock options in NeuroSigma, the licensee of some of his inventions, and he currently is on leave as its chief medical officer and senior vice president. He is director of the Los Angeles TMS Institute, Inc., and chief executive officer at HeartCloud, Inc., and the BrainCloud Corporation, as well as Professor Emeritus at UCLA.
Boadie Dunlop, M.D., Section Editor, Applied Armamentarium, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia. Grant/Research: Axome, Assurex, Acadia, Janssen, NIMH, Takeda
Mayada Akil, M.D., Georgetown University Hospital Department of Psychiatry
Bringing Neuroscience to the Bedside
Joseph Cooper, M.D., University of Illinois at Chicago, Department of Psychiatry
Alexander Korb, M.D., Semel Institute for Neuroscience, UCLA Psychiatry
Mayada Akil, M.D.; Georgetown University Hospital, Department of Psychiatry
Drs. Cooper and Akil have nothing to disclose. Dr. Korb is a consultant for and owns shares in Brainsonix Inc. and receives author royalties from New Harbinger Publications.
Therapeutic Uses of Seizures in Neuropsychiatry
M. Justin Coffey, M.D., Medical Director, Center for Brain Stimulation, The Menninger Clinic Associate Professor of Psychiatry & Behavioral Sciences Baylor College of Medicine
Joseph J. Cooper, M.D., Associate Professor of Clinical Psychiatry University of Illinois at Chicago
Dr. Cooper has nothing to disclose. Dr. Coffey reports authorship royalties from UpToDate 2. Authorship royalties from MedLink Neurology
Ketamine for Treatment-Resistant Mood Disorders
Lawrence T. Park, M.D., Tolulope B. Falodun, BS, and Carlos A. Zarate Jr., M.D., Section on Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD
Dr. Zarate is listed as a co-inventor on a patent for the use of ketamine in major depression and suicidal ideation; as a co-inventor on a patent for the use of (2R,6R)-hydroxynorketamine, (S)-dehydronorketamine, and other stereoisomeric dehydro and hydroxylated metabolites Tolulope of (R,S)-ketamine metabolites in the treatment of depression and neuropathic pain; and as a co-inventor on a patent application for the use of (2R,6R)- hydroxynorketamine and (2S,6S)-hydroxynorketamine in the treatment of depression, anxiety, anhedonia, suicidal ideation, and post-traumatic stress disorders. He has assigned his patent rights to the U.S. government but will share a percentage of any royalties that may be received by the government. All other authors have no conflict of interest to disclose, financial or otherwise.
Transcranial Direct Current Stimulation in Psychiatry: What Psychiatrists Need to Know
Amin Zand Vakili, M.D., Ph.D, Yosef Berlow, M.D., Ph.D., Noah Stephen Philip, M.D., Center for Neurorestoration and Neurotechnology, Providence VA Medical Center, Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence RI,
Linda Leigh Carpenter, M.D., Alpert Medical School of Brown University, Providence RI, and Butler Hospital, Neuromodulation Research Facility, Providence, RI.
In the last three years, Dr. Philip has received grant support (through clinical trial contracts) from Neuronetics and Neosync. Dr. Carpenter reports: Consultant: Magstim LTD, Feelmore Labs Inc.; Grant/Research: Neuronetics, NeoSync, Janssen. Dr. Berlow and Dr. Zand Vakili report no conflicts.
A Critical Review and Synthesis of Clinical and Neurocognitive Effects of Non-Invasive Neuromodulation Antidepressant Therapies
Shawn M. McClintock, Ph.D., MSCS, Neurocognitive Research Laboratory, Department of Psychiatry, UT, Southwestern Medical Center, Dallas, TX, USA; Division of Brain Stimulation and Neurophysiology, Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC
Dr. McClintock reports grant support from the National Institutes of Health (NIH), and teaching honoraria from TMS HealthSolutions.
Elisa Kallioniemi, Ph.D., Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX, USA
Dr. Kallioniemi reports no competing interests
Donel M. Martin, Ph.D., Black Dog Institute, Sydney, Australia; School of Psychiatry, University of New South Wales, Sydney, Australia
Dr. Martin reports grant support from the Brain and Behavior Foundation, travel support from Miyuki Giken, and a speaker’s honorarium from Lundbeck.
Joseph U. Kim, Ph.D., Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, Utah, USA
Dr. Kim reports grant support from the National Institutes of Health (NIH).
Sara L. Weisenbach, Ph.D., Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, Utah, USA; VA Salt Lake City, Mental Health Program, Salt Lake City, Utah, USA.
Dr. Weisenbach reports grant support from the National Institutes of Health (NIH) and the Department of Veterans Affairs
Christopher C. Abbott, M.D., M.S., Department of Psychiatry, University of New Mexico School of Medicine.
Dr. Abbott reports grant support from the National Institutes of Health (NIH).
How Neuroscience is Informing Treatments: Ethical Issues
Kristina Thurin, M.D., Zehra N. Aftab, M.D., Joseph J. Cooper, M.D., University of Chicago, Department of Psychiatry and Behavioral Neuroscience. The authors report no financial relationships with commercial interests.
Neuroscience and the Future of Psychiatry
Michael J. Travis, M.D., Associate Professor, Director of Residency Training, Department of Psychiatry, Western Psychiatric Institute and Clinic of UPMC Dr Travis reports no financial relationships with commercial interests
American Psychiatric Association Staff Involved in Planning:
Tristan Gorrindo, M.D., Director, Division of Education, APA – no conflicts
Kristen Moeller, Director of CME, Associate Director of FOCUS -- no conflicts